4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001437749-26-035009
Options or other derivatives
- CEO and Chairman acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Javitt Jonathan C · CEO and Chairman
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-28 | Grant or award : show line 1 in the form Restricted Stock Unit | +150,000 | 150,000 | D |
Loading xslF345X06/rdgdoc.xml…